HEALON® GV OVD
HEALON GV® OVDs offer high viscosity for deep anterior chamber creation and maximum space for maneuverability with minimal damage to the cornea or other delicate ocular tissues.
Compared to Alcon’s VISCOAT and Bausch & Lomb’s Ocucoat OVDs,* the HEALON GV® OVD produced considerably less endothelial cell loss.1
*VISCOAT is a trademark of Novartis International AG; Ocucoat is a trademark of Bausch & Lomb Inc.
Holzer MP, Tetz MR, Auffarth GU,Welt R, Volcker HE. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg.2001;27(2):213-218.